Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rising Pharmaceuticals has launched the generic version of the 75mg/*5mL strength of Clindamycin Palmitate Hydrochloride for Oral Solution, USP (Pediatric).
Subscribe to our email newsletter
Clindamycin Palmitate Hydrochloride used to treat infections caused by bacteria, is a FDA approved generic version of Pfizer’s Cleocin Pediatric.
According to IMS Health data, Clindamycin Palmitate Hydrochloride had sales nearly $59m for the twelve months ended 30 June 2012.
Rising Pharmaceuticals is a finished dosage form generics subsidiary to ACETO Corporation, which markets, sells and distributes products for human health, pharmaceutical ingredients and performance chemicals.